source
- EU regulators endorse Eli Lilly’s oral GLP-1 pill orforglipronThe European Medicines Agency’s human medicines committee (CHMP) has given a positive opinion on Eli Lilly’s oral GLP-1 medication, orforglipron, providing the drug with EU regulatory backing. The…
- FDA issues warning letters to drug makers and a lab over CGMP and GLP violationsFDA sent warning letters to several drug manufacturers for not meeting current good manufacturing practice (CGMP) requirements. The letters point to issues such as ensuring final product sterility…